Resistance to antibiotics and characterization of helicobacter pylori strains isolated from antrum and body from adults in Mexico

Microbial Drug Resistance

Volumn 17, Issue 2, 2011, Pages 149-155

  Ayala, Guadalupe ^a   Galván Portillo, Marcia ^a   Chihu, Lilia ^a   Fierros, Geny ^a   Sánchez, Alejandro ^a   Carrillo, Berta ^a   Román, Adolfo ^b   López Carrillo, Lizbeth ^a   Silva Sánchez, Jesús ^a  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b UAG   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; METRONIDAZOLE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CAGA GENE; EPSILOMETER TEST; FEMALE; GENOTYPE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; MEXICO; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE; STOMACH BIOPSY; VACA GENE;

ADULT; AGE FACTORS; ANTI-BACTERIAL AGENTS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; BIOPSY; CLARITHROMYCIN; DRUG RESISTANCE, BACTERIAL; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MEXICO; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREVALENCE; SEX FACTORS; STOMACH;

HELICOBACTER PYLORI;

EID: 79957639688     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2010.0154     Document Type: Article

References (34)

1. Atherton, J.C., P. Cao, R.M. Peek, Jr., M.K. Tummuru, M.J. Blaser, and T.L. Cover. 1995. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J. Biol. Chem. 270:17771-17777.
2. Atherton, J.C., T.L. Cover, R.J. Twells, M.R. Morales, C.J. Hawkey, and M.J. Blaser. 1999. Simple and accurate PCRbased system for typing vacuolating cytotoxin alleles of Helicobacter pylori. J. Clin. Microbiol. 37:2979-2982. (Pubitemid 29391920)
3. Bago, J., Z.B. Halle, D. Strinic, N. Kucisec, D. Jandric, M. Bevanda, M. Tomic, and A. Bilic. 2002. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate-vs. omeprazole-based one-week triple therapies in H. pylori eradication-a randomised controlled trial. Wien Klin Wochenschr. 114:448-453. (Pubitemid 34764236)
4. Chattopadhyay, S., R. Patra, T. Ramamurthy, A. Chowdhury, A. Santra, G.K. Dhali, S.K. Bhattacharya, D.E. Berg, G.B. Nair, and A.K. Mukhopadhyay. 2004. Multiplex PCR assay for rapid detection and genotyping of Helicobacter pylori directly from biopsy specimens. J. Clin. Microbiol. 42: 2821-2824. (Pubitemid 38750217)
5. Chen, L.T., J.T. Lin, J.J. Tai, G.H. Chen, H.Z. Yeh, S.S. Yang, H.P. Wang, S.H. Kuo, B.S. Sheu, C.M. Jan, W.M. Wang, T.E. Wang, C.W. Wu, C.L. Chen, I.J. Su, J. Whang-Peng, and A.L. Cheng. 2005. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric highgrade transformed MALT lymphoma. J. Natl. Cancer Inst. 97:1345-1353. (Pubitemid 41487802)
6. Cheung, T.K., and B.C. Wong. 2008. Treatment of Helicobacter pylori and prevention of gastric cancer. J. Dig. Dis. 9: 8-13. (Pubitemid 351188934)
7. Chihu, L., G. Ayala, A. Mohar, A. Hernandez, R. Herrera-Goepfert, G. Fierros, H. Gonzalez-Marquez, and J. Silva. Antimicrobial resistance and characterization of Helicobacter pylori strains isolated from Mexican adults with clinical outcome. J. Chemother. 17:270-276.
8. DeLoney, C.R., and N.L. Schiller. 2000. Characterization of an In vitro-selected amoxicillin-resistant strain of Helicobacter pylori. Antimicrob. Agents Chemother. 44:3368-3373. (Pubitemid 33009497)
9. Demir, M., H.S. Gokturk, N.A. Ozturk, H. Arslan, E. Serin, and U. Yilmaz. 2009. Clarithromycin resistance and efficacy of clarithromycin-containing triple eradication therapy for Helicobacter pylori infection in type 2 diabetes mellitus patients. South Med. J. 102:1116-1120.
10. Ducons, J.A., S. Santolaria, R. Guirao, M. Ferrero, M. Montoro, and F. Gomollon. 1999. Impact of clarithromycin resistance on the effectiveness of a regimen for Helicobacter pylori: a prospective study of 1-week lansoprazole, amoxycillin and clarithromycin in active peptic ulcer. Aliment. Pharmacol. Ther. 13:775-780. (Pubitemid 29276847)
11. Fischbach, L., and E.L. Evans. 2007. Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori. Aliment. Pharmacol. Ther. 26:343-357. (Pubitemid 47063149)
12. Garza-Gonzalez, E., G.I. Perez-Perez, O. Alanis-Aguilar, R. Tijerina-Menchaca, H.J. Maldonado-Garza, and F.J. Bosques-Padilla. 2002. Antibiotic susceptibility patterns of Helicobacter pylori strains isolated from northeastern Mexico. J. Chemother. 14:342-345. (Pubitemid 34988924)
13. Graham, D.Y., and A. Shiotani. 2008. New concepts of resistance in the treatment of Helicobacter pylori infections. Nat. Clin. Pract. Gastroenterol. Hepatol. 5:321-331. (Pubitemid 351803603)
14. Graham, D.Y., G.M. Lew, P.D. Klein, D.G. Evans, D.J. Evans, Jr., Z.A. Saeed, and H.M. Malaty. 1992. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann. Intern. Med. 116:705-708. (Pubitemid 23033112)
15. Graham, D.Y., and L. Fischbach. 2010. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut 59:1143-1153.
16. Graham, D.Y., W.A. de Boer, and G.N. Tytgat. 1996. Choosing the best anti-Helicobacter pylori therapy: effect of antimicrobial resistance. Am. J. Gastroenterol. 91:1072-1076. (Pubitemid 26175462)
17. Gwee, K.A., L. Teng, R.K. Wong, K.Y. Ho, D.S. Sutedja, K.G. Yeoh. 2009. The response of Asian patients with functional dyspepsia to eradication of Helicobacter pylori infection. Eur. J. Gastroenterol. Hepatol. 21:417-424.
18. Hunt, R.H., C.A. Fallone, and A.B. Thomson. 1999. Canadian Helicobacter pylori Consensus Conference update: infections in adults. Canadian Helicobacter Study Group. Can. J. Gastroenterol. 13:213-217. (Pubitemid 29221769)
19. Ikezawa, K., H. Kashimura, M. Kojima, T. Aikawa, A. Nakahara, H. Mutoh, N. Tanaka. 1999. Pretreatment antimicrobial susceptibilities of paired gastric Helicobacter pylori isolates: antrum versus corpus. Helicobacter 4:218-221. (Pubitemid 129688361)
20. Iovene, M.R., M. Romano, A.P. Pilloni, B. Giordano, F. Montella, S. Caliendo, M.A. Tufano. 1999. Prevalence of antimicrobial resistance in eighty clinical isolates of Helicobacter pylori. Chemotherapy 45:8-14. (Pubitemid 29027530)
21. Kim, J.J., J.G. Kim, and D.H. Kwon. 2003. Mixed-infection of antibiotic susceptible and resistant Helicobacter pylori isolates in a single patient and underestimation of antimicrobial susceptibility testing. Helicobacter 8:202-206. (Pubitemid 36712404)
22. Mahachai, V., D. Thong-Ngam, P. Noophun, S. Tumwasorn, and P. Kullavanijaya. 2006. Efficacy of clarithromycinbased triple therapy for treating Helicobacter pylori in Thai non-ulcer dyspeptic patients with clarithromycin-resistant strains. J. Med. Assoc. Thai. 89 Suppl 3:S74-S78.
23. Masuda, H., T. Hiyama, M. Yoshihara, S. Tanaka, F. Shimamoto, K. Haruma, and K. Chayama. 2003. Necessity of multiple gastric biopsies from different sites for detection of clarithromycin-resistant Helicobacter pylori strains. Scand. J. Gastroenterol. 38:942-946. (Pubitemid 37153622)
24. Ong, S.P., and A. Duggan. 2004. Eradication of Helicobacter pylori in clinical situations. Clin. Exp. Med. 4:30-38. (Pubitemid 39303589)
25. Pimanov, S.I., E.V. Makarenko, A.V. Voropaeva, M.E. Matveenko, and E.V. Voropaev. 2008. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer. J. Gastroenterol. Hepatol. 23: 1666-1671.
26. Rimbara, E., N. Noguchi, M. Tanabe, T. Kawai, Y. Matsumoto, and M. Sasatsu. 2005. Susceptibilities to clarithromycin, amoxycillin and metronidazole of Helicobacter pylori isolates from the antrum and corpus in Tokyo, Japan, 1995-2001. Clin. Microbiol. Infect. 11:307-311. (Pubitemid 40443837)
27. Romano, M., M.R. Iovene, M.I. Russo, A. Rocco, R. Salerno, D. Cozzolino, A.P. Pilloni, M.A. Tufano, D. Vaira, and G. Nardone. 2008. Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates. J. Clin. Pathol. 61:1112-1125.
28. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr. Eval. Carcinog. Risks. Hum. 1994. 61:1-241.
29. Sugimoto, M., and Y. Yamaoka. 2009. Virulence factor genotypes of Helicobacter pylori affect cure rates of eradication therapy. Arch. Immunol. Ther. Exp. (Warsz). 57:45-56.
30. Torres, J., L. Lopez, E. Lazcano, M. Camorlinga, L. Flores, and O. Munoz. 2005. Trends in Helicobacter pylori infection and gastric cancer in Mexico. Cancer Epidemiol. Biomarkers Prev. 14:1874-1877. (Pubitemid 41161192)
31. Torres, J., M. Camorlinga-Ponce, G. Perez-Perez, A. Madrazo-De la Garza, M. Dehesa, G. Gonzalez-Valencia, and O. Munoz. 2001. Increasing multidrug resistance in Helicobacter pylori strains isolated from children and adults in Mexico. J. Clin. Microbiol. 39:2677-2680. (Pubitemid 32606258)
32. Valle, J., M. Kekki, P. Sipponen, T. Ihamaki, and M. Siurala. 1996. Long-term course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study. Scand. J. Gastroenterol. 31:546-550. (Pubitemid 26196134)
33. Wong, B.C., W.H. Wang, D.E. Berg, F.M. Fung, K.W. Wong, W.M. Wong, K.C Lai, C.H. Cho, W.M. Hui, and S.K. Lam. High prevalence of mixed infections by Helicobacter pylori in Hong Kong: metronidazole sensitivity and overall genotype. Aliment. Pharmacol. Ther. 15:493-503.
34. Wu, D.C., P.I. Hsu, J.Y. Wu, A.R. Opekun, C.H. Kuo, I.C. Wu, S.S. Wang, A. Chen, W.C. Hung, and D.Y. Graham. Sequential and concomitant therapy with four drugs is equally effective for eradication of H. pylori infection. Clin. Gastroenterol. Hepatol. 8:36-41.e1.